Valuation: DocMorris AG

Market Cap 510M 633M 550M 471M 887M 60.41B 903M 6.04B 2.37B 30B 2.38B 2.32B 101B P/E 2026 *
-6.66x
P/E 2027 * -13.3x
Enterprise Value 710M 881M 765M 655M 1.23B 84.09B 1.26B 8.41B 3.29B 41.76B 3.31B 3.24B 140B EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.54x
Free-Float
64.09%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 27/04/2022
Director of Finance/CFO 56 30/09/2024
Chief Tech/Sci/R&D Officer - 31/10/2024
Director TitleAgeSince
Chairman 68 27/04/2022
Director/Board Member 53 22/05/2019
Director/Board Member 56 31/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 631M
+0.71%+6.97%-21.31%-29.70% 16.27B
+1.13%+6.89%-26.84%-35.33% 7.4B
-3.56%+3.80%-17.76%-7.93% 6.46B
0.00%+4.32%-4.82%-29.25% 4.06B
+0.37%+4.11%-27.05%-46.30% 3.28B
+0.79%+1.97%+9.94%-31.82% 3.19B
+0.46%+3.22%-42.45%-23.15% 3.02B
+2.65%+7.10%-9.89%+5.73% 2.72B
+0.51%+4.46%+101.17% - 2.6B
Average +0.34%+4.88%-4.33%-24.72% 5.44B
Weighted average by Cap. +0.27%+5.58%-12.84%-26.34%

Financials

2026 *2027 *
Net sales 1.24B 1.53B 1.33B 1.14B 2.15B 146B 2.19B 14.64B 5.73B 72.7B 5.76B 5.63B 244B 1.39B 1.72B 1.5B 1.28B 2.41B 164B 2.46B 16.44B 6.44B 81.65B 6.47B 6.32B 275B
Net income -81.01M -100M -87.23M -74.71M -141M -9.59B -143M -959M -376M -4.76B -377M -369M -16.01B -43.68M -54.15M -47.03M -40.28M -75.87M -5.17B -77.25M -517M -202M -2.57B -203M -199M -8.63B
Net Debt 200M 248M 215M 185M 348M 23.68B 354M 2.37B 927M 11.76B 932M 911M 39.55B 236M 293M 254M 218M 410M 27.93B 417M 2.79B 1.09B 13.87B 1.1B 1.07B 46.65B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10.44CHF
Average target price
10.22CHF
Spread / Average Target
-2.12%

Quarterly revenue - Rate of surprise